USP publishes draft supply chain integrity chapter
The USP has published draft supply chain integrity guidance outlining steps to stop counterfeit or adulterated drugs reaching patients.
Archives for January 9, 2012
Icon says it will be Shire's sole central labs provider and share clinical dev work with PRA
Ireland-based CRO Icon will do all of Shire’s central laboratory work under a new strategic alliance announced today.
Toray takes stake in Japanese CMO to boost life sciences biz
Toray Industries has acquired a stake in a Japanese CMO and ingredient supplier as part of its push into life sciences.
Novartis to take $120m charge to fix US plant, recall OTC drugs
Novartis expects to take a $120m charge to improve a US manufacturing plant and recall drugs after the FDA sent it a 483.
Research needed on drug residues in water says Recipharm award winner
Further analysis is needed to assess the risk posed by low level pharmaceutical contamination of water supplies says the winner of Recipharm’s 2011 environmental award.
EU preclinical CROs partner on profiling & discovery services
European CROs Dualsystems Biotech and NiKem Research have partnered to offer drug profiling and discovery services.
India to inspect six China manufacturers following GMP complaints
Chinese companies exporting drugs in bulk will come under the microscope next month when the Indian government sends a team of officials to inspect manufacturing plants.
Rousselot buys Eastman Gelatine Corp in bid for pharma growth
Rousselot says its acquisition of Eastman Kodak’s Gel Corporation will boost its gelatine production capacity and help it meet soaring drug industry demand.
AMRI to streamline US workforce and mothball R&D lab
Albany Molecular Research (AMRI) says ‘streamlining’ plan will focus on its drug licensing unit not its contract API research, development and manufacturing services division.